Literature DB >> 16284139

Imaging of penile neoplasms.

Ajay K Singh1, Anuradha Saokar, Peter F Hahn, Mukesh G Harisinghani.   

Abstract

The assessment of penile cancer on the basis of clinical findings alone can often result in inaccurate staging and suboptimal treatment. Imaging of primary penile cancer and metastatic lymphadenopathy can help optimize planning of both primary tumor resection and treatment for lymph node metastases. Magnetic resonance (MR) imaging is the most accurate imaging modality in the assessment of primary penile cancers, which usually manifest as solitary, ill-defined infiltrating tumors that are hypointense on both T1- and T2-weighted MR images. T2-weighted MR imaging allows delineation of the tumor margin and of any extension into the penile shaft. On gadolinium-enhanced T1-weighted images, the tumors enhance to a greater extent than do the corpora cavernosa. In addition, the recently introduced technique known as lymphotrophic nanoparticle-enhanced MR imaging can help identify metastatic lymph node disease. However, further studies will be needed to determine the role of this imaging technique in clinical practice. Computed tomography does not clearly depict the local extension of primary penile cancer; however, it is useful in assessing metastases and postoperative complications. RSNA, 2005.

Entities:  

Mesh:

Year:  2005        PMID: 16284139     DOI: 10.1148/rg.256055069

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  11 in total

Review 1.  Multimodality imaging findings of infection-induced tumors.

Authors:  Moataz Soliman; Nicholas Guys; Peter Liu; Mariam Moshiri; Christine O Menias; Vincent M Mellnick; Hatice Savas; Mohamed Badawy; Khaled M Elsayes; Ayman H Gaballah
Journal:  Abdom Radiol (NY)       Date:  2022-09-07

2.  Penile metastasis from rectal carcinoma: A case report.

Authors:  Jun-Jie Sun; Shi-Yu Zhang; Jun-Jie Tian; Bai-Ye Jin
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

3.  Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection.

Authors:  G Petralia; G Villa; E Scardino; E Zoffoli; G Renne; O de Cobelli; M Bellomi
Journal:  Radiol Med       Date:  2008-05-13       Impact factor: 3.469

4.  Imaging in primary penile cancer: current status and future directions.

Authors:  Rohit Kochhar; Ben Taylor; Vijay Sangar
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

5.  Solitary metastasis to the penis from prostate adenocarcinoma - a case report.

Authors:  Hui Lin Wong; Haiyuan Shi; Li-Tsa Koh
Journal:  J Radiol Case Rep       Date:  2019-12-31

6.  F-18 fluorodeoxy glucose positron emission tomography/computed tomography findings in a rare case of penile leiomyosarcoma.

Authors:  Kuruva Manohar; Bhagwant Rai Mittal; Raghava Kashyap; Anish Bhattacharya; Nandita Kakkar; Uttam Kumar Mete
Journal:  J Clin Imaging Sci       Date:  2011-12-17

7.  Patient with penile metastasis from prostate cancer and survival over 5 years: A case report with longitudinal evaluation using computed tomography and magnetic resonance imaging.

Authors:  Nana Fujita; Ryo Kurokawa; Risa Kaneshima; Munetaka Machida; Go Kawai; Tomoki Wada; Masamichi Takahashi; Moto Nakaya; Naoya Sakamoto; Shinichi Cho; Osamu Abe; Yujiro Matsuoka
Journal:  Radiol Case Rep       Date:  2021-03-26

8.  Magnetic resonance imaging of solid urethral and peri-urethral lesions.

Authors:  Andrew Del Gaizo; Alvin C Silva; Dora M Lam-Himlin; Brian C Allen; John Leyendecker; Akira Kawashima
Journal:  Insights Imaging       Date:  2013-05-19

9.  A report of two deep-seated noncutaneous penile tumors: more than meets the eye.

Authors:  Kerry Thomas; Philippe Spiess; Jamie T Caracciolo
Journal:  Radiol Case Rep       Date:  2017-08-12

10.  Penile secondary lesions: a rare entity detected by PET/CT.

Authors:  Tima Davidson; Liran Domachevsky; Yogev Giladi; Eddie Fridman; Zohar Dotan; Barak Rosenzweig; Raya Leibowitz; Jennifer Ben Shimol
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.